BOLD
Price:
$1.41
Market Cap:
$31.67M
Boundless Bio, Inc., a clinical-stage oncology company, focuses on developing innovative cancer therapies aimed at addressing the significant unmet needs of patients with oncogene amplified tumors. Their core strategy involves targeting extrachromosomal DNA (ecDNA). The company's lead product candidate, BBI-355, an orally administered inhibitor of checkpoint kinase 1 (CHK1), is currently in Phase 1/2 clinical trials for patients suffering from oncogene amplified cancers. Additionally, Boundless Bio is advancing BBI-825, another oral inhibitor, this one targeting ribonucleotide reductase (RNR), also in Phase 1/2 clinical development for cancer patients exhibiting resistance gene amplification...[Read more]
Industry
Biotechnology
IPO Date
2016-07-20
Stock Exchange
NASDAQ
Ticker
BOLD
According to Boundless Bio, Inc.’s latest financial reports and current stock price. The company's current ROE is -53.60%. This represents a change of 296.08% compared to the average of -13.53% of the last 4 quarters.
The mean historical ROE of Boundless Bio, Inc. over the last ten years is -9.75%. The current -53.60% ROE has changed 449.79% with respect to the historical average. Over the past ten years (40 quarters), BOLD's ROE was at its highest in in the December 2022 quarter at 14.42%. The ROE was at its lowest in in the December 2017 quarter at -57.62%.
Average
-9.75%
Median
-36.24%
Minimum
-58.99%
Maximum
66.01%
Discovering the peaks and valleys of Boundless Bio, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 35.96%
Maximum Annual ROE = 66.01%
Minimum Annual Increase = -326.89%
Minimum Annual ROE = -58.99%
| Year | ROE | Change |
|---|---|---|
| 2025 | -58.99% | 35.96% |
| 2024 | -43.39% | -211.54% |
| 2023 | 38.90% | -30.77% |
| 2022 | 56.19% | -14.89% |
| 2021 | 66.01% | -326.89% |
| 2018 | -29.10% | -49.51% |
| 2017 | -57.62% | 15.28% |
The current ROE of Boundless Bio, Inc. (BOLD) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-21.16%
5-year avg
11.74%
10-year avg
-9.75%
Boundless Bio, Inc.’s ROE is less than Q32 Bio Inc. (230.68%), greater than NextCure, Inc. (-186.96%), greater than Plus Therapeutics, Inc. (-198.48%), greater than Intensity Therapeutics, Inc. (-136.82%), less than Iterum Therapeutics plc (602.38%), greater than AN2 Therapeutics, Inc. (-52.35%), less than Pluri Inc. (203.55%), greater than Rallybio Corporation (-14.39%), greater than Sonnet BioTherapeutics Holdings, Inc. (-518.10%), greater than TAO Synergies Inc. (-120.29%),
| Company | ROE | Market cap |
|---|---|---|
| 230.68% | $161.49M | |
| -186.96% | $5.56M | |
| -198.48% | $12.12M | |
| -136.82% | $6.83M | |
| 602.38% | $1.60M | |
| -52.35% | $129.89M | |
| 203.55% | $20.41M | |
| -14.39% | $84.35M | |
| -518.10% | $8.43M | |
| -120.29% | $11.90M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Boundless Bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Boundless Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Boundless Bio, Inc.'s ROE?
How is the ROE calculated for Boundless Bio, Inc. (BOLD)?
What is the highest ROE for Boundless Bio, Inc. (BOLD)?
What is the 3-year average ROE for Boundless Bio, Inc. (BOLD)?
What is the 5-year average ROE for Boundless Bio, Inc. (BOLD)?
How does the current ROE for Boundless Bio, Inc. (BOLD) compare to its historical average?